Compare Sanofi SA (SNY) vs YieldMax Universe Fund of Option Income ETFs (YMAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sanofi SA vs YieldMax Universe Fund of Option Income ETFs — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while YieldMax Universe Fund of Option Income ETFs trades at $7.7. The key difference: Sanofi SA pays a 5.5% dividend while YieldMax Universe Fund of Option Income ETFs pays none, and Sanofi SA is trading nearer its 52-week high, YieldMax Universe Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals.
| SNY | YMAX | |
|---|---|---|
Market Cap | $104.83B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $52.34 | $14.00 |
52-Week Low | $41.33 | $7.51 |
Enterprise Value | $121.32B | — |
Dividend Yield | 5.5% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →About YieldMax Universe Fund of Option Income ETFs
YMAX is an actively managed 'fund of funds' that provides equal-weighted exposure to the full suite of YieldMax option income ETFs. It is designed to generate high current income by aggregating the premiums from various single-stock and thematic covered call strategies, offering a diversified approach to high-yield option investing.
Read more on YMAX →
